Caricamento...
Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
We performed post-mortem studies on two patients with advanced Parkinson’s disease 8 and10 years following AAV2-neurturin (CERE120) gene therapy, the longest post-mortem trophic factor gene therapy cases reported to date. CERE120 was delivered to the putamen bilaterally in one case (10 years post-su...
Salvato in:
| Pubblicato in: | Brain |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089653/ https://ncbi.nlm.nih.gov/pubmed/32203581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awaa020 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|